Agilent, Danaher could be potential buyers of Qiagen - analyst
Source: SeekingAlpha
2026-01-20 13:53:41 ET
More on Qiagen
- Qiagen N.V. (QGEN) Presents at German Investment Seminar 2026 - Slideshow
- Qiagen N.V. (QGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Qiagen N.V. (QGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Qiagen gains on report it's weighing options amid takeover interest
- Qiagen signals $2.38 adjusted EPS target and $500M share repurchase while advancing single-cell strategy
Read the full article on Seeking Alpha
For further details see:
Agilent, Danaher could be potential buyers of Qiagen - analyst
Qiagen N.V.
NASDAQ: QGEN
QGEN Trading
-3.03% G/L:
$41.90 Last:
1,050,835 Volume:
$42.64 Open:
QGEN Latest News
March 10, 2026 05:05:00 pm
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
QGEN Stock Data
$10,633,318,293
203,932,295
N/A
22
N/A
Biotechnology & Life Sciences
Healthcare
NL
Venlo
